Levodopa-induced alterations in speech rate in advanced Parkinson's disease

Acta Neurologica Belgica

Volumn 106, Issue 1, 2006, Pages 19-22

  De Letter, Miet ^a   Santens, Patrick ^a   De Bodt, Marc ^b   Boon, Paul ^a   Van Borsel, John ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Dysfluency; Dyskinesia; Levodopa; Parkinson; Reading; Speech rate

Indexed keywords

LEVODOPA;

ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; DISEASE SEVERITY; DYSKINESIA; FEMALE; FLUENCY DISORDER; HUMAN; MALE; PARKINSON DISEASE; POST HOC ANALYSIS; READING; RESPIRATORY TRACT DISEASE; SPEECH ANALYSIS; SPEECH DISORDER; SPEECH INTELLIGIBILITY; SPEECH RATE; TASK PERFORMANCE; WILCOXON SIGNED RANKS TEST;

EID: 33744471898     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Brown P., Marsden C. D. What do the basal ganglia do? Lancet, 1998, 351: 1801-1804.
2. Braun et al. Speech rate as a sticky switch: a multiple lesion case analysis of mutism and hyperlalia. Brain Lang, 2004, 89: 243-252.
3. Canter G. Speech characteristics of patients with Parkinson's disease: I.Intensity, pitch and duration. J. Speech Hear Dis., 1963, 28: 221-229.
4. Darley F., Aronson A., Brown J. Differential diagnosis patterns of dysarthria. J. Speech Hear Res., 1969, 12: 246-269.
5. Enderby P. N. (1983). Frenchay Dysarthria Assessment. San Diego: College-Hill Press.
6. Goberman A., McMillan J. Relative speech timing in Parkinson's disease. Cont. Iss. Comm. Science and Dis., 2005, 32: 22-29.
7. Ho A. K., Bradshaw J. L., Iansek R., Alfredson R. Speech volume regulation in Parkinson's disease: Effects of implicit cues and explicit instructions. Neuropsychologia, 1999; 37: 1453-1460.
8. International phonetic association (1974). The principles of the international association, London.
9. Lang A., Lozano A. Parkinson's disease: first of two parts. N. Engl. J. Med., 1998, 339: 1044-1053.
10. Le Dorze G., Ryalls J., Brassard C., Boulanger N., Ratte D. A comparison of the prosodic characteristics of the speech of people with Parkinson's disease and Friedreich's ataxia with neurologically with neurologically normal speakers. Folia Phoniatrica et Logopaedica, 1998, 50: 1-9.
11. Metter J., Hanson W. Clinical and acoustical variability in hypokinetic dysarthria. J. Comm. Disord., 1986, 19: 347-366.
12. Rigrodsky S., Morrison E. Speech changes in parkinsonism during L-DOPA therapy: preliminary findings. J. Am. Geratr. Soc., 1970, 18: 142-151.
13. Robb et al. Speaking rates of American and New Zealand varieties of English. Clin. Linguist. Phon., 2004, 18: 1-15.
14. Santens P., De Letter M., Van Borsel J., De Reuck J., Caemaert J. Lateralized effects of subthalamic nucleus stimulation on different aspects of speech in Parkinson's disease. Brain and Language, 2003, 87: 253-258.
15. Solomon N., Hixon T. Speech breathing in Parkinson's Disease. J. Speech Hear Res., 1993, 36: 294-310.
16. Torp J., Hammen V. Perception of Parkinsonian speech rate. J. Med Speech-Lang. Pathol., 2000, 8: 323-329.
17. Wolfe V., Garvin J., Bacon M., Waldrop W. Speech changes in Parkinson's Disease during treatment with L-DOPA. J. Comm. Dis., 1975, 8: 271-279.